BP delivered strong Q2 results, beating earnings and revenue estimates due to strong profitability in its core business.

T-Mobile debuts investment-grade baby bonds (TMUSZ, TMUSL, TMUSI) maturing 2069–2070. Explore yields up to 6.22% and strong ...

Eldorado's stock has performed exceptionally well this year, rising more than 50% on the back of gold's momentum and Skouries ...

Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...

The real assets portfolio was the primary detractor due to negative returns for energy stocks and U.S. real estate investment ...

Fourth quarter sales increased 10% to $273.1 million driven by an acceleration of $30 million in sales that were anticipated to take place in the 2026 financial year. The acceleration of sales is a ...

Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's ...

Tonix's Tonmya received FDA approval, marking the first new fibromyalgia therapy in 15 years and driving a post-market stock ...

Downgrading Banco do Brasil to underperform after consecutive weak quarters, driven by surging defaults in agribusiness and ...

IHF offers exposure to large-cap healthcare, AI-driven growth, and demographic trends, with a recent dip creating a strong ...

I've made costly mistakes in my REIT investing journey, lessons that reshaped my approach and strategy. Learn why smarter ...

Dole trades at fair value with modest growth, high debt, and slim margins, limiting upside despite deleveraging and stable ...